Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nginache Nampota Nkomba

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Cell Host & Microbe|May 13, 2022
RTS,S today and tomorrow's scienceNginache Nampota Nkomba, Cristiana Cairo, Miriam K Laufer
Open Forum Infectious Diseases|June 5, 2023
Using Typhoid Conjugate Vaccines to Prevent Disease, Promote Health Equity, and Counter Drug-Resistant Typhoid FeverNginache Nampota-Nkomba, Megan E Carey, Leslie P Jamka, et al.
AIDS Care|January 7, 2024
Prevalence and risk factors of detectable HIV viral load among pregnant women with HIV infection seeking antenatal care in Southern MalawiFelix A Mkandawire, Andrea Buchwald, Nginache Nampota-Nkomba, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 17, 2025
Association between Maternal HIV and Adverse Birth Outcomes in the Era of Universal Antiretroviral Therapy in MalawiNginache Nampota-Nkomba, Andrea Buchwald, Osward M Nyirenda, et al.
Research Square|July 17, 2025
Adverse Birth Outcomes Associated with SARS-CoV-2 Infection Among Pregnant Women with and without HIV: A Longitudinal Cohort StudyIbrahim Ahmed El-Imam, Abra Rachida Koudjra, Nginache Nampota-Nkomba, et al.
Open Forum Infectious Diseases|April 15, 2024
An Upsurge of Measles Cases in Mali-a Consequence of Pandemic-associated Disruption in Routine ImmunizationNginache Nampota-Nkomba, Adama Mamby Keita, Jane Juma, et al.
Trials|January 26, 2024
DON in pediatric cerebral malaria, a phase I/IIA dose-escalation safety study: study protocol for a clinical trialNginache Nampota-Nkomba, Osward M Nyirenda, Jane Mallewa, et al.
Eclinicalmedicine|March 4, 2025
Immunogenicity and reactogenicity of a booster dose of a typhoid conjugate vaccine (TCV) in Malawian pre-school childrenNginache Nampota-Nkomba, Osward M Nyirenda, Shrimati Datta, et al.
AIDS (London, England)|April 16, 2025
Penile human papillomavirus prevalence in circumcised sexual minority men living with and without HIVNginache Nampota-Nkomba, Kareshma Mohanty, Ruxton Adebiyi, et al.
The Journal of Infectious Diseases|February 26, 2026
Safety, tolerability, and pharmacokinetics of 6-diazo-5-oxo-L-norleucine (DON) in Malawian adults with and without malaria: a Phase I dose-escalation clinical trialBrittany A Riggle, Athanasios Chamzas, Mathangi Gopalakrishnan, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Cell Host & Microbe|May 13, 2022
RTS,S today and tomorrow's scienceNginache Nampota Nkomba, Cristiana Cairo, Miriam K Laufer
Open Forum Infectious Diseases|June 5, 2023
Using Typhoid Conjugate Vaccines to Prevent Disease, Promote Health Equity, and Counter Drug-Resistant Typhoid FeverNginache Nampota-Nkomba, Megan E Carey, Leslie P Jamka, et al.
AIDS Care|January 7, 2024
Prevalence and risk factors of detectable HIV viral load among pregnant women with HIV infection seeking antenatal care in Southern MalawiFelix A Mkandawire, Andrea Buchwald, Nginache Nampota-Nkomba, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 17, 2025
Association between Maternal HIV and Adverse Birth Outcomes in the Era of Universal Antiretroviral Therapy in MalawiNginache Nampota-Nkomba, Andrea Buchwald, Osward M Nyirenda, et al.
Research Square|July 17, 2025
Adverse Birth Outcomes Associated with SARS-CoV-2 Infection Among Pregnant Women with and without HIV: A Longitudinal Cohort StudyIbrahim Ahmed El-Imam, Abra Rachida Koudjra, Nginache Nampota-Nkomba, et al.
Open Forum Infectious Diseases|April 15, 2024
An Upsurge of Measles Cases in Mali-a Consequence of Pandemic-associated Disruption in Routine ImmunizationNginache Nampota-Nkomba, Adama Mamby Keita, Jane Juma, et al.
Trials|January 26, 2024
DON in pediatric cerebral malaria, a phase I/IIA dose-escalation safety study: study protocol for a clinical trialNginache Nampota-Nkomba, Osward M Nyirenda, Jane Mallewa, et al.
Eclinicalmedicine|March 4, 2025
Immunogenicity and reactogenicity of a booster dose of a typhoid conjugate vaccine (TCV) in Malawian pre-school childrenNginache Nampota-Nkomba, Osward M Nyirenda, Shrimati Datta, et al.
AIDS (London, England)|April 16, 2025
Penile human papillomavirus prevalence in circumcised sexual minority men living with and without HIVNginache Nampota-Nkomba, Kareshma Mohanty, Ruxton Adebiyi, et al.
The Journal of Infectious Diseases|February 26, 2026
Safety, tolerability, and pharmacokinetics of 6-diazo-5-oxo-L-norleucine (DON) in Malawian adults with and without malaria: a Phase I dose-escalation clinical trialBrittany A Riggle, Athanasios Chamzas, Mathangi Gopalakrishnan, et al.
Pageof 2